2m 2m 2m 2m 2m 2m 2m
KAIROS PHARMA (KAPA)
NYSE
$0.55+$0.01 (+1.84%)
Price as of Oct 22, 2026 7:40 PM EDT- $2.0MMarket Cap
- -92.23%1-Year Change
- BiotechnologyIndustry
KAIROS PHARMA (KAPA)
$0.55+$0.01 (+1.84%)
KAPA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.54 | ||
Change | -$0.007 (-1.22%) | ||
Open | $0.59 | ||
High | $0.60 | ||
Low | $0.54 | ||
Previous Close | $0.58 | ||
Volume | 84,101 | ||
30-Day Average Volume | 880,376 | ||
1-Week Change | -22.40% | ||
1-Month Change | -67.79% | ||
1-Year Change | -92.23% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 3.4M | ||
Total Assets | $4.5M | ||
Market Cap | $2.0M | ||
Enterprise Value | -$673,989.00 | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.0M | ||
EBIT | $0.00 | ||
EBITDA | $22,000.00 | ||
Net Working Capital | $2.9M | ||
EPS | -$0.42 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 09/01/2026 | ||
Earnings & Revenue